PDS Biotechnology
PDSB
PDSB
40 hedge funds and large institutions have $3.05M invested in PDS Biotechnology in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $6.07M → $3.05M (-$3.01M)
Holders
40
Holding in Top 10
–
Calls
$200K
Puts
–
Top Buyers
| 1 | +$105K | |
| 2 | +$79.1K | |
| 3 | +$50.8K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$37.6K |
| 5 |
Renaissance Technologies
New York
|
+$33.2K |
Top Sellers
| 1 | -$2M | |
| 2 | -$148K | |
| 3 | -$147K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$79.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$26.3K |
